Quanome Technologies, Inc. (QNME)
NASDAQ: QNME · Real-Time Price · USD
0.7352
+0.4212 (134.14%)
Aug 4, 2026, 12:35 PM EDT - Market open

Quanome Technologies Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
1.3317.7918.3212.879.61
Revenue Growth
-89.76%-2.86%42.28%34.02%-
Gross Profit
5.682.883.722.561.81
Operating Income
-4.9-4.96-0.530.25-0.12
Net Income
-3.55-5.25-0.230.98-0
Earnings Per Share
-0.27-0.69-0.040.16-0.00
EPS Growth
-----

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Pharmaceutical Distribution (china)
7.162.76---
Cross-border Freight Solutions (u.s.)
-15.03---
Transportation - Air Freight
--18.3212.879.61
Total
22.1817.7918.3212.879.61

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
1.34.960.120.170.37
Total Debt
0.526.334.613.223.93
Net Cash (Debt)
0.78-1.37-4.49-3.04-3.56
Net Cash Growth
-----
Net Cash Per Share
0.04-0.18-0.75-0.51-0.59

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-4.83-2.66-0.050.040.26
Capital Expenditures
-0.04-0.15--0.02-0.12
Free Cash Flow
-4.87-2.81-0.050.020.14
Free Cash Flow Growth
----84.69%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
427.87%16.18%20.29%19.92%18.83%
Operating Margin
-368.92%-27.88%-2.87%1.92%-1.23%
Pretax Margin
-380.99%-27.79%-1.61%7.84%-0.03%
Profit Margin
-393.18%-29.49%-1.25%7.84%-0.03%
FCF Margin
-366.74%-15.77%-0.29%0.16%1.43%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
1.200.501.31--